Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft

ClinicalTrials.gov ID: NCT00617279

Public ClinicalTrials.gov record NCT00617279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison of Primary Patency Between GORE PROPATEN Vascular Graft and Disadvantaged Autologous Vein Graft For Below-Knee Arterial Bypass (PRODIGY Study)

Study identification

NCT ID
NCT00617279
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
W.L.Gore & Associates
Industry
Enrollment
31 participants

Conditions and interventions

Interventions

  • GORE PROPATEN Vascular Graft Device
  • Disadvantaged Autologous Vein Graft Procedure

Device · Procedure

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Jan 31, 2010
Completion
Jan 31, 2010
Last update posted
Jan 11, 2012

2007 – 2010

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
University Of Alabama Medical Center Birmingham Alabama 35294
Georgetown University Hospital Washington D.C. District of Columbia 20007
Emory University School of Medicine Atlanta Georgia 30322
Medical Center of Central Georgia Macon Georgia 31201
University of Chicago Chicago Illinois 60637
Vascular Specialty Associates Baton Rouge Louisiana 70809
University of Maryland Medical Center Baltimore Maryland 21201
Brigham and Women's Hospital Boston Massachusetts 02115
Albany Medical Center Albany New York 12208
Stonybrook University Medical Center Stony Brook New York 11794
Montifiore Medical Center The Bronx New York 10467
Cleveland Clinic Cleveland Ohio 44195
Greenville Hospital System Greenville South Carolina 29605
University of Tennessee medical Center Knoxville Tennessee 37920
The Methodist Hospital System Houston Texas 77030
Peripheral Vascular Associates San Antonio Texas 78205
Sentara Norfolk Hospital Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00617279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2012 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00617279 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →